BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17353570)

  • 1. Pharmacist membership in a medical group's diabetes health management program.
    Brooks AD; Rihani RS; Derus CL
    Am J Health Syst Pharm; 2007 Mar; 64(6):617-21. PubMed ID: 17353570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice.
    Kiel PJ; McCord AD
    Ann Pharmacother; 2005 Nov; 39(11):1828-32. PubMed ID: 16219894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling.
    Rodriguez de Bittner M; Chirikov VV; Breunig IM; Zaghab RW; Shaya FT
    J Am Pharm Assoc (2003); 2017; 57(1):102-108.e4. PubMed ID: 27769877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service.
    McCord AD
    Pharmacotherapy; 2006 Feb; 26(2):248-53. PubMed ID: 16466329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention.
    Odegard PS; Goo A; Hummel J; Williams KL; Gray SL
    Ann Pharmacother; 2005 Mar; 39(3):433-40. PubMed ID: 15701763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study.
    Jacobs M; Sherry PS; Taylor LM; Amato M; Tataronis GR; Cushing G
    J Am Pharm Assoc (2003); 2012; 52(5):613-21. PubMed ID: 23023841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An employer-based, pharmacist intervention model for patients with type 2 diabetes.
    Iyer R; Coderre P; McKelvey T; Cooper J; Berger J; Moore E; Kushner M
    Am J Health Syst Pharm; 2010 Feb; 67(4):312-6. PubMed ID: 20133537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement.
    Anaya JP; Rivera JO; Lawson K; Garcia J; Luna J; Ortiz M
    Am J Health Syst Pharm; 2008 Oct; 65(19):1841-5. PubMed ID: 18796426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes Associated With a Collaborative Pharmacist-Endocrinologist Diabetes Intense Medical Management "Tune Up" Clinic in Complex Patients.
    Morello CM; Christopher ML; Ortega L; Khoan J; Rotunno T; Edelman SV; Henry RR; Hirsch JD
    Ann Pharmacother; 2016 Jan; 50(1):8-16. PubMed ID: 26546580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and clinical outcomes of pharmacist-managed diabetes care clinics.
    Morello CM; Zadvorny EB; Cording MA; Suemoto RT; Skog J; Harari A
    Am J Health Syst Pharm; 2006 Jul; 63(14):1325-31. PubMed ID: 16809752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service.
    Johnson CL; Nicholas A; Divine H; Perrier DG; Blumenschein K; Steinke DT
    J Am Pharm Assoc (2003); 2008; 48(6):722-30. PubMed ID: 19019800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of a pharmacist-directed peer support program among adolescents with diabetes.
    Sims LM; Haines SL
    J Am Pharm Assoc (2003); 2011; 51(6):766-9. PubMed ID: 22068200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
    Salvo MC; Brooks AM
    Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial.
    Jameson JP; Baty PJ
    Am J Manag Care; 2010 Apr; 16(4):250-5. PubMed ID: 20394460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic.
    Cioffi ST; Caron MF; Kalus JS; Hill P; Buckley TE
    Ann Pharmacother; 2004 May; 38(5):771-5. PubMed ID: 15031417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist leads primary care team to improve diabetes care.
    Choe HM; Bernstein SJ; Mueller BA; Walker PC; Stevenson JG; Standiford CJ
    Am J Health Syst Pharm; 2009 Apr; 66(7):622-4. PubMed ID: 19299368
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
    Padiyara RS; D'Souza JJ; Rihani RS
    J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study finds pharmacist program improves diabetes.
    Dis Manag Advis; 2008 Feb; 14(2):9-10. PubMed ID: 18309726
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical impact of a pharmacist + health coach chronic disease management program in a rural free clinic.
    Hurst H; Dunn S; Fuji KT; Gilmore J; Wilt S; Webster S; Parikh P
    J Am Pharm Assoc (2003); 2021; 61(4):442-449. PubMed ID: 33775539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.